|
|
|
Research Week 2025: Celebrating discovery, impact and everyone who has the courage to try
November 28,
2025
-
Research Week at The Ottawa Hospital was a great success, full of groundbreaking science, interactive learning opportunities and inspiring stories.
|
|
|
|
|
|
Global study identifies gene responsible for rare neurodevelopment disorder
November 26,
2025
-
A new international study led by researchers at The Ottawa Hospital and Seattle Children’s Hospital has identified a novel neurodevelopmental disorder caused by mutations in the SMARCA1 gene
|
|
|
|
|
|
ScaleReady grant to fuel development of innovative cancer treatments at The Ottawa Hospital’s Biotherapeutics Manufacturing Centre
November 25,
2025
-
ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReadyTM, announced today that the Biotherapeutics Manufacturing Centre (BMC) at The Ottawa Hospital’s Research Institute (OHRI) has been awarded a ...
|
|
|
|
|
|
Research reveals when Duchenne muscular dystrophy starts and supports possible new treatment approach
November 19,
2025
-
Duchenne muscular dystrophy (DMD), a rare inherited disorder, usually begins with mild muscle weakness between the ages of three and five, progressing to more severe problems and eventually death around age 30.
|
|
|
|
|
|
New scientist profile: Dr. Yi Liu maps the mind to better understand genes and neurological conditions
November 19,
2025
-
Dr. Yi Liu, Scientist in the Regenerative Medicine Program and the Neuroscience Program at the Ottawa Hospital Research Institute and Assistant Professor at the University of Ottawa, is uncovering how brain cells know which genes to turn on or ...
|
|
|
|
See all news items | See only press releases | Search for news and experts by disease / specialty
|
|
|
Media contacts
Jennifer Ganton
Director, Communications and Public Relations,
613-614-5253
jganton@ohri.ca
|
